Santhera Pharmaceuticals Holding AG (SANN.SW) SIX

Currency In CHF

AD

Valuation

Market Cap163.98M
Enterprise Value239.31M
P/E Ratio-4.18
PEG Ratio0.14
Price/Sales Ratio3.07
Price/Book Ratio-18.09
Enterprise/Revenue4.04
Enterprise/EBITDA-10.18

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterDecember 31, 2025

Profitability

Profit Margin-0.64
Operating Margin-0.49
AD

Management Effectiveness

Return On Assets-0.33
Return On Equity6.85

Income Statement

Revenue77.19M
Revenue/Share5.76
Gross Profit14.47M
EBITDA-32.13M
Net Income-49.24M
Diluted EPS-3.78

Balance Sheet

Total Cash22.44M
Total Cash/Share1.68
Total Debt97.77M
Total Debt/Equity-8.27
Current Ratio1.29
Book Value Per Share-0.88

Price History

52-Week Change30.39
52-Week High18.84
52-Week Low9.38
Moving Average 50 Days16.68
Moving Average 200 Days13.92

Statistics

Average Volume93,145
Shares Outstanding14.83M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:10
Last Split DateJuly 03, 2023
AD